The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt-Jakob disease

Transfusion

Volumn 44, Issue 10, 2004, Pages 1475-1478

  Wilson, Kumanan ^a   Ricketts, Maura N ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CREUTZFELDT JAKOB DISEASE; DECISION MAKING; DISEASE TRANSMISSION; EVIDENCE BASED MEDICINE; HUMAN; INSTITUTIONAL CARE; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; RISK MANAGEMENT;

CREUTZFELDT-JAKOB SYNDROME; DECISION MAKING; DISEASE TRANSMISSION, HORIZONTAL; HEALTH POLICY; HUMANS; RISK; UNIVERSAL PRECAUTIONS;

EID: 4844222158     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.04116.x     Document Type: Review

References (23)

1. Foster KR, Vecchia P, Repacholi MH. Science and the precautionary principle. Science 2000;288:979-80.
2. Kriebel D, Tickner J. The precautionary principle and public health: reenergizing public health through precaution. Am J Public Health 2001;91:1351-5.
3. Wilson K, Wilson M, Graham I, Hebert P. The application of the precautionary principle to the health sector: lessons learned from decisions concerning variant Creutzfeldt-Jakob disease and the blood supply. Transfus Med Rev 2002;17:89-94.
4. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
5. Further precautionary measures on blood products announced (Internet). 98/076. London: Department of Health; 1998 Feb 26. Available from: http://www.newsrelease-archive.net/coi/depts/GDH/coi8292d.ok
6. Committee on safety of medicines completes review of blood products (Internet). 98/182. London: Department of Health; 1998 May 13.
7. vCJD Working Party of the Standing Advisory Committee on Transfusion Transmitted Infections. United Kingdom Blood Transfusion Services position statement (Internet). Hertforshire: National Blood Service; 2002 Oct (updated 2003 Dec). Available from: http://www.hbsef.org/brief12bloodservicedoc.htm
8. Government accepts advice on leucodepletion from Spongi-form Encephalopathy Advisory Committee (Internet). 98/295. London: Department of Health; 1998 Jul 17. Available from: http://www.newsrelease-archive.net/coi/ depts/GDH/coi4084e.ok
9. Directive 99-02: donor exclusion to address theoretical risk of transmission of variant CJD through the use of commercial blood products (Internet). Ottawa: Therapeutic Products Programme, Health Canada; 1999 Aug 17. Available from: http://www.hc-sc.gc.ca/hpfb-dgpsa/bgtd-dpbtg/d99-02_e.html
10. Guidance for industry: revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob Disease (CJD) and variant Creutzfeldt-Jakob Disease (vCJD) by blood and blood products (Internet). Rockville (MD): U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologies Evaluation and Research (CBER); 2002 Jan. Available from: http://www.fda.gov/cber/gdlns/cjdvcjd.pdf
11. Lee K. France acts on threat of BSE transmission by blood: the French blood transfusion authorities are banning donors who might have become exposed to BSE in the UK (Internet). The Scientist 2001 Jan 23. Available from: http://www.biomedcentral.com/news/20010123/05/
12. Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;349:99-100.
13. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet 2000;356:999-1000.
14. Hunter N, Foster J, Chong A, et al. Transmission of prion diseases by blood transfusion. J Gen Virol 2002;83:2897-905.
15. Herzog C, Sales N, Etchegaray N, et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 2004;363:422-8.
16. Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:422-8.
17. Wilson K, Hebert P, Laupacis A, et al. A policy analysis of major decisions related to Creutzfeldt-Jakob disease and the blood supply. Can Med Assoc J 2001;165:59-65.
18. Bird SM. Recipients of blood or blood products "at vCJD risk." Br Med J 2004;328:118-9.
19. Ward L. Minister outlines steps to boost image of MMR jabs. The Guardian 2002 Feb 21.
20. Attaran A, Maharaj R. Ethical debate: doctoring malaria, badly: the global campaign to ban DDT. BMJ 2000;321:1403-5.
21. Miller HI, Conko G. Precaution without principle. Nat Biotechnol 2001;19:302-3.
22. Famine-hit Zambia rejects GM food aid (Internet). BBC News 2002 Oct 29. Available from: http://news.bbc.co.uk/1/hi/world/africa/2371675.stm
23. Goklany IM. From precautionary principle to risk-risk analysis. Nat Biotechnol 2002;20:1075.